Trial Profile
Phase II Trail of Sorafenib Combined With Transarterial Chemoembolization in HBV-infected Patients With Intermediate Hepatocellular Carcinoma
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Doxorubicin/ethiodized oil
- Indications Liver cancer
- Focus Therapeutic Use
- 23 Mar 2012 New trial record